2025 英卡思巴黎国际年会
大会日程

针对您所在时区的直播课程/会议的时间

时区参照: (UTC+02:00) Europe, Paris

时区

时区:改换时区

If you are logged in, change your default time zone in your account

DEXLEVO Symposium - Endless Possibilities of Fully Liquid PCL Collagen Stimulator GOURI: Real Anti-Aging from Head to Toe

会议室： Amphi Bleu - Level 2
日期： 2025年 1月 31日星期五从 16:00 至 18:00
组织形式： 企业卫星会 > 参展公司进行的促销和教育会议

本场演讲内容

小时	讲者	演讲标题	讲稿摘要	数字
16:00	Hosung CHOI 医师	Exploring Liquid PCL Stimulator for Facial Dynamic Rejuvenation: How Does It Work	查看	144685
16:20	Jason Khin Loong YIP 医师	From Experience to Excellence: Insights and Strategies with Liquid PCL to Achieve Superior Results		144687
16:40	Bilal MALIK 医师	GOURI Combination Protocols: Solid+Liquid Threads Synergy		144690
17:00	Rassapoom SUMAETHEIWIT 医师	GOURI for Face: Advanced Injection Techniques in My Practice		144691
17:20	Rena HIRATA 医师	Expanding the Application Areas of Polycaprolactone: Safe and Efficient Techniques		144695
17:40	Rena HIRATA 医师	Panel Discussion		144696
17:40	Hosung CHOI 医师	Panel Discussion		146306
17:40	Jason Khin Loong YIP 医师	Panel Discussion		146307
17:40	Bilal MALIK 医师	Panel Discussion		146308
17:40	Rassapoom SUMAETHEIWIT 医师	Panel Discussion		146309

进入前一场会议

下一个会议室 (Room 242 - Level 2)

Hosung CHOI 医师

美容整型外科医师

韩国

其他作者 :

Exploring Liquid PCL Stimulator for Facial Dynamic Rejuvenation: How Does It Work

Objectives: 1. To assess the mechanism of action of liquid PCL when administered into the skin.
2. To determine the most effective and safe injection techniques for liquid PCL application.
3. To establish optimal protocols for maintaining long-lasting skin rejuvenation results.
4. To evaluate the long-term safety profile of liquid PCL following subdermal injection.

Introduction: The medical aesthetics field is experiencing a shift in focus from volume replacement to biostimulation. In line with this trend, various biostimulators have gained prominence for their ability to rejuvenate the skin while enhancing facial contours. PCL is widely recognized as one of the most potent biostimulators, with a long history of use in the medical field. The development of liquid PCL through innovative technology has overcome these limitations, transforming PCL into a safe and effective biostimulator with powerful regenerative capabilities.

Materials / method: Eleven participants received one or two treatment sessions at three-month intervals. Each session involved the injection of liquid PCL (1 to 3 ml per session) using a 25-gauge blunt cannula and a gentle fanning technique, targeting the immediate subdermal plane. The primary treatment areas focused on the midface. Skin roughness and pore size were measured using Antera 3D imaging and facial skin tightening effects were evaluated using the Morpheus 3D system at baseline and post-treatment.

Results: Liquid PCL injections have demonstrated significant improvements in overall skin texture of the upper and mid-face, including a reduction in pore size and enhanced skin radiance. Notably, a reduction in the alar-tragus length was observed in most subjects, indicating improved skin tightening that contributes to a smaller, more contoured facial appearance. The rejuvenation and tightening effects of the skin were sustained for up to six months following the injections. The procedure was well-tolerated, with minor adverse events, such as temporary edema, reported in only one patient.

Conclusion: 1. Liquid PCL effectively delivers long-term improvements in skin quality and tightening in the upper and mid-face.
2. Liquid PCL offers sustained neocollagenesis and tissue remodeling while minimizing the risk of nodules or granuloma formation.
3. Optimized injection techniques with liquid PCL enable noticeable 3D skin rejuvenation from within, achieving results without volumizing effects, thereby avoiding mid-face overfilling.